Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Neutral

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

XORTX Therapeutics Inc. Common Stock (XRTX)

https://www.xortx.com

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/04/2018

Market Cap

4,268,248

Shares Outstanding

2,000,000

Weighted SO

1,998,848

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

CNTX --.--%

NRSN --.--%

BTTX --.--%

QNRX --.--%

ENSC --.--%

Beta

-0.1220

Last Div

0.0000

Range

1.21-67.716

Chg

0.0200

Avg Vol

65304

Mkt Cap

4268248

Exch

NASDAQ

Country

CA

Phone

N/A

DCF Diff

0.3039

DCF

1.2641

Div Yield

0.0000

P/S

0.0000

EV Multiple

-0.0878

P/FV

1.4350

Div Yield %

0.0000

P/E

-1.0719

PEG

-0.0154

Payout

0.0000

Current Ratio

13.2150

Quick Ratio

13.2150

Cash Ratio

11.2500

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

638.9399

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

0.0398

ROA

-0.5512

ROE

-0.6472

ROCE

-0.9191

NI/EBT

1.0229

EBT/EBIT

0.6212

EBIT/Rev

0.0000

Debt Ratio

0.0023

D/E

0.0056

LT Debt/Cap

0.0000

Total Debt/Cap

0.0056

Int Coverage

0.0000

CF/Debt

-387.4126

Equity Multi

2.4289

Rec Turnover

0.0000

Pay Turnover

0.5713

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-2.2362

FCF/Share

-2.2483

Cash/Share

1.5772

OCF/Sales

0.0000

FCF/OCF

1.0054

CF Coverage

-387.4126

ST Coverage

-387.4126

CapEx Coverage

-184.1502

Div&CapEx Cov

-184.1502

P/BV

1.4350

P/B

1.4350

P/S

0.0000

P/E

-1.0719

P/FCF

-0.7815

P/OCF

-0.6574

P/CF

-0.6574

PEG

-0.0154

P/S

0.0000

EV Multiple

-0.0878

P/FV

1.4350

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jul 22, 23:59 XORTX Completes Non-Brokered Private Placement of Units GlobeNewswire Inc. Apr 17, 23:45 XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency GlobeNewswire Inc. Jan 17, 22:00 XORTX Announces Change of Auditor GlobeNewswire Inc. Sep 06, 21:30 XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders GlobeNewswire Inc. Nov 30, 07:30 XORTX Announces US ATM Offering GlobeNewswire Inc. Oct 27, 17:30 XORTX Announces Results of Special Meeting of Shareholders

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.00 01/31/2014 01/13/2014 02/04/2014 02/17/2014
0.00 10/15/2013 10/03/2013 10/17/2013 11/01/2013
0.00 07/11/2013 07/01/2013 07/15/2013 07/30/2013
0.00 04/16/2013 04/04/2013 04/18/2013 05/02/2013
0.00 12/24/2012 12/18/2012 12/27/2012 12/31/2012
0.00 10/12/2012 10/02/2012 11/30/-0001 10/30/2012
0.00 07/17/2012 07/05/2012 11/30/-0001 08/01/2012
0.00 04/10/2012 03/29/2012 11/30/-0001 04/26/2012
0.00 02/13/2012 02/01/2012 11/30/-0001 02/29/2012
0.00 11/22/2011 11/14/2011 11/30/-0001 12/09/2011
0.00 08/10/2011 08/01/2011 11/30/-0001 08/26/2011